Healthcare Services

Viral Gastroenteritis Market Impacted by Rising Gastrointestinal Disease Prevalence Driving Market Growth

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Viral Gastroenteritis Market From 2026 To 2030?

The market size for viral gastroenteritis has experienced significant growth in recent years. It is projected to expand from $7.06 billion in 2025 to $7.43 billion in 2026, representing a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to improvements in public health awareness, broader healthcare access, the availability of basic diagnostic tools, a rise in the use of oral rehydration solutions, and enhanced disease reporting systems.

The viral gastroenteritis market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $9.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast timeframe is primarily driven by factors such as increasing investments in infectious disease surveillance, a rising demand for rapid point-of-care diagnostics, the expansion of vaccination and prevention programs, a growing focus on pediatric healthcare, and the increasing adoption of digital disease monitoring. Key trends anticipated during this period encompass an increasing focus on rapid diagnostic testing, a rising demand for supportive care therapies, a growing emphasis on infection control and prevention, the expansion of oral rehydration and zinc therapy usage, and enhanced surveillance of viral outbreaks.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

What Key Drivers Are Fueling The Growth Of The Viral Gastroenteritis Market?

The growing incidence of gastrointestinal disorders is poised to fuel the expansion of the viral gastroenteritis market in the coming years. Gastrointestinal (GI) disorders encompass any disease found within or on the gastrointestinal tract, and viral gastroenteritis medications and diagnostic approaches offer appropriate treatment for individuals suffering from these conditions. For instance, data from September 2023 in the Impact of IBD Report 2023, published by the IBD Clinical and Research Centre, revealed that in Canada, inflammatory bowel disease (IBD) had a prevalence of 825 per 100,000 in 2023, affecting over 320,000 people in Canada. With an anticipated annual increase of 2.44% in prevalence, it is projected that by 2035, 1.1% of the population, or 470,000 Canadians, will be living with IBD. Consequently, the rising prevalence of gastrointestinal disorders is stimulating the growth of the viral gastroenteritis market.

How Are Segments Identified Within The Viral Gastroenteritis Market Segment Framework?

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Antimotility Agents: Loperamide, Diphenoxylate

4) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

What Trends Are Influencing The Viral Gastroenteritis Market?

Major companies active in the viral gastroenteritis market are creating new products, such as PCR kits for gastrointestinal infectious diseases, to gain a competitive advantage. Polymerase Chain Reaction (PCR) kits are molecular biology tools crafted for the amplification and detection of specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based company specializing in molecular diagnostic solutions, introduced 10 Real-Time PCR Kits aimed at the precise detection of gastrointestinal pathogens, establishing a comprehensive Total PCR Solution when combined with their extraction solution and PCR system. These Real-Time PCR Kits are designed to identify a range of bacterial, viral, and parasitic pathogens linked to gastrointestinal infections. This includes conditions caused by various bacterial pathogens such as Campylobacter, Salmonella, Shigella, and Clostridioides difficile, as well as viral agents like Adenovirus, Rotavirus, Astrovirus, and Norovirus. This innovative solution offers a streamlined approach, from sample pre-processing through to PCR amplification analysis.

Who Are The Companies Competing Within The Viral Gastroenteritis Market?

Major companies operating in the viral gastroenteritis market are Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company, Novartis AG, Johnson and Johnson, Moderna Inc, Bharat Biotech International Ltd

Get The Full Viral Gastroenteritis Market Report:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Where Is The Viral Gastroenteritis Market Most Concentrated Geographically?

North America was the largest region in the viral gastroenteritis market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Viral Gastroenteritis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Browse Through More Reports Similar to the Global Viral Gastroenteritis Market 2026, By The Business Research Company

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Gastrointestinal Pathogen Testing Market Report

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Oral Expectorant Market Report

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795